Rottendorf Pharma is much more than a contract manufacturer for solid dosage forms. With a unique company structure, and operating under the philosophies of Total Process Ownership (TPO) and Total Technological Mastering (TTM), Rottendorf has become a CDMO with one of the strongest customer alignments in the market and creates significant added value for customers. Rottendorf does not manufacture any of its own products, and it does not hold any product licenses. We are never in competition with our clients.
Rottendorf Pharma’s vision is to be known in the global solid dosage CDMO market as the most customer-oriented CDMO for solid dosage forms. This is achieved through the Total Process Ownership service concept combined with the highest competency in pharmaceutical technology (Total Technological Mastering) and best-in-class on-time-delivery. As a result, Rottendorf is the business partner of choice.
Rottendorf is totally owned and controlled by the Rottendorf Foundation.
Main purpose of the Rottendorf Foundation is to promote scientific work in the field of pharmaceutical research as well as charitable projects. Strongly defined foundation bylaws ensure that the company can not be sold, can act economically totally independent and can focus on sustainable and outstanding corporate social responsibility. All these aspects in combination create significant advantages for our customers and therefore lead to a competitive advantage for our global positioned technology company. The foundation background enables our employees to focus solely on the needs of our customers and their products.
Rottendorf Pharma delivers an innovative service approach. TPO means that Rottendorf is a thinking partner and assumes total ownership on given tasks so that our customers achieve their final goals. We minimize the customer’s resource requirements and interfaces.
Rottendorf Pharma has the highest competency in pharmaceutical technology. By applying our TTM philosophy, we create value to our customers by adding our in-depth scientific and technological knowledge of the product design and its manufacturing. We master the product rather than just executing its production.
Rottendorf Pharma guarantees best-in-class on-time-delivery while creating a robust and efficient supply chain. This is achieved with reliable and stable production processing times, advanced supply chain planning processes, and deviation-free manufacturing. We get it right the first time.
"To become the CDMO of choice, we at Rottendorf Pharma work very hard to reduce the total costs of outsourcing for our customers while setting product quality in the center of our attention. To achieve this, it is our job to minimize our customers oversight requirements as well as providing all technical skills required to master the product and its manufacturing process. To do so, we developed our unique Total Process Ownership (TPO) service model along with our focus on pharmaceutical expertise by applying our Total Technological Mastering (TTM) approach. All of this is anchored in our corporate culture, so as to assume a leading position in our business segment."
Rottendorf’s Code of Conduct states the expectations Rottendorf has as an employer towards employees and sets forth the standards for our business behavior. All employees must comply with our Code of Conduct, regardless of the nature of their work. Rottendorf’s Code of Conduct contains guidance in the areas of products and services, personal integrity, corporate integrity, employment, company assets, responsible business, and comprehensive compliance management. It also provides examples and information on where to find more detailed guidance on the various topics. Rottendorf’s employees are encouraged to seek help and advice whenever in doubt about correct business behaviors and to speak up in case of a compliance concern or suspected violation of the Code of Conduct.
